Condition: PICS · PICS-F · Sponsor: Medical University of Vienna
Post-Intensive Care Syndrome (PICS) refers to long-term cognitive, physical, and psychological impairments that can arise after intensive care treatment. These symptoms may begin within 24 hours of ICU admission and persist for years. Affected patients and their families (PICS-F) face significant burdens, with up to 94% of relatives impacted. Given its high prevalence and socioeconomic impact, this prospective registry study aims to identify risk factors and long-term consequences of PICS and PICS-F. The study consists of six modules, starting with data collection during ICU stays and continuing with follow-ups at various intervals post-discharge (up to five years). The primary goal is to investigate diagnostic and therapeutic strategies, while secondary objectives include identifying risk factors, determining impairment severity, and exploring biological mechanisms. Standardized questionnaires and biological samples (blood) are used for data collection.
This description comes directly from the study's public registry record.
PICS-DACH Steering Committee · +4314040041020 · pics-dach-sc@listserv.muv.ac.at
Study Coordination AAI MUV · aai-research@muv.ac.at
Always discuss trial participation with your own doctor first.
| Medical University of Vienna | Vienna, State of Vienna, Austria | Recruiting |
| Universitätsklinikum Augsburg | Augsburg, Bavaria, Germany | Not Yet Recruiting |
| Universitätsklinikum Würzburg | Würzburg, Bavaria, Germany | Not Yet Recruiting |
| Charité - Universitätsmedizin Berlin | Berlin, State of Berlin, Germany | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07290712